Could this Healthcare Stock really climb 266.40% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [AI Revolution could affect your retirement]( [Watch this urgent briefing now.]( --------------------------------------------------------------- April 10, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Forget Tesla... Apple Car May Be The #1 EV Play]( Valley insider, Luke Lango, says his contacts are going crazy over Apple's latest project. Apple is preparing to upend the auto industry with their own EV... and this $5 stock could soar 40X once it goes live! [Click here to learn more.]( --------------------------------------------------------------- [Albertsons Companies]( Symbol: [ACI]( Recent Price: $21.16 Average Analyst Price Target: $26.85 (26.92%) Market Cap: $11.28B Last Year's EPS: $0.75 Consensus EPS Forecast: $0.68 Expected Earnings Date: Apr 11 2023 Recent Analyst Action: Joe Feldman, analyst at Telsey Advisory, reiterates coverage on [Albertsons Companies (ACI)]( in the Consumer Goods sector with a Hold rating and a price target of $27.25 (5 days ago). [TipRanks.com]( also reports that [Albertsons Companies]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $26.85. The target pricing ranges from a high forecast of $30.00 down to a low forecast of $24.00. [Albertsons Companies (ACI)](’s last closing price was $21.16 which would put the average price target at 26.92% upside. Here are 3rd party ratings for [ACI](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Buy, Top 40% (101 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [CarMax]( Symbol: [KMX]( Recent Price: $64.97 Average Analyst Price Target: $59.63 (-8.22%) Market Cap: $10.17B Last Year's EPS: $0.98 Consensus EPS Forecast: $0.2 Expected Earnings Date: Apr 11 2023 Recent Analyst Action: Steven Shemesh, analyst at RBC Capital, reiterates coverage on [CarMax (KMX)]( in the Consumer Goods sector with a Buy rating and a price target of $60.00 (5 days ago). [TipRanks.com]( also reports that [CarMax]( currently has 8 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $59.63. The target pricing ranges from a high forecast of $75.00 down to a low forecast of $40.00. [CarMax (KMX)](’s last closing price was $64.97 which would put the average price target at -8.22% upside. Here are 3rd party ratings for [KMX](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 26% (66 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Disturbing Truth About Biden's New Program To Seize Your Cash]( s disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now. [Get The Rest Of The Details Here]( --------------------------------------------------------------- [Mainz Biomed B.V.]( Symbol: [MYNZ]( Recent Price: $6.34 Average Analyst Price Target: $18.00 (183.91%) Market Cap: ― Last Year's EPS: -$0.49 Consensus EPS Forecast: -$0.43 Expected Earnings Date: Apr 11 2023 Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [Mainz Biomed B.V. (MYNZ)]( in the Healthcare sector with a Buy rating and a price target of $25.00 (1 week ago). [TipRanks.com]( also reports that [Mainz Biomed B.V.]( currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $18.00. The target pricing ranges from a high forecast of $25.00 down to a low forecast of $11.00. [Mainz Biomed B.V. (MYNZ)](’s last closing price was $6.34 which would put the average price target at 183.91% upside. Here are 3rd party ratings for [MYNZ](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 32% (79 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Nurix Therapeutics]( Symbol: [NRIX]( Recent Price: $8.87 Average Analyst Price Target: $32.50 (266.40%) Market Cap: $440.59M Last Year's EPS: -$0.95 Consensus EPS Forecast: -$0.87 Expected Earnings Date: Apr 11 2023 Recent Analyst Action: Joel Beatty, analyst at Robert W. Baird, reiterates coverage on [Nurix Therapeutics (NRIX)]( in the Healthcare sector with a Buy rating and a price target of $31.00 (2 weeks ago). [TipRanks.com]( also reports that [Nurix Therapeutics]( currently has 11 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $32.50. The target pricing ranges from a high forecast of $53.00 down to a low forecast of $20.00. [Nurix Therapeutics (NRIX)](’s last closing price was $8.87 which would put the average price target at 266.40% upside. Here are 3rd party ratings for [NRIX](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 32% (79 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Warning: Insiders are going all in on these stocks]( €™s the #1 rule of investing? Follow the money. In other words… Where are the insiders putting their cash? Well guys, I followed the money… And it led me to a little ragtag group of stocks you wouldn’t even know exists. [See what I discovered inside this free report.]( --------------------------------------------------------------- [OrganiGram Holdings]( Symbol: [OGI]( Recent Price: $0.63 Average Analyst Price Target: $1.47 (133.37%) Market Cap: $190.50M Last Year's EPS: >-$0.01 Consensus EPS Forecast: -$0.01 Expected Earnings Date: Apr 11 2023 Recent Analyst Action: Andrew Partheniou, analyst at Stifel Nicolaus, reiterates coverage on [OrganiGram Holdings (OGI)]( in the Basic Materials sector with a Buy rating (4 weeks ago). [TipRanks.com]( also reports that [OrganiGram Holdings]( currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $1.47. The target pricing ranges from a high forecast of $1.60 down to a low forecast of $1.33. [OrganiGram Holdings (OGI)](’s last closing price was $0.63 which would put the average price target at 133.37% upside. Here are 3rd party ratings for [OGI](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Bottom 37% (158 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Biden's Puppet Master... REVEALED]( you ever suspected that Joe Biden’s not really running America… And that there’s someone else pulling the strings… You’re right! [Click here to see his identity… and discover how he’s about to destroy your way of life]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software